The latest filing states the doubt was alleviated.
“Following the closing of the Initial Public Offering, the Private Placement and the Over-Allotment Option, the Company has capital in excess of the funds deposited in the Trust Account and/or used to fund offering expenses that will be available to the Company for general working capital purposes. Accordingly, management has since re-evaluated the Company's liquidity and financial condition and determined that sufficient capital exists to sustain operations one year from the date the unaudited condensed financial statements was issued and therefore substantial doubt has been alleviated.”View the 10-Q filed Aug 13, 2026
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
The closing range uses available history since Jul 24, 2026; less than a full year is stored.
Illustrative technical + ownership context — a signal mix, not investment advice.
KPI extraction has been attempted, but no publishable series is available from the examined filings. This is not evidence that the company reports no KPIs.
| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
APMCR
this stock
AmperCap Acquisition Co
|
$198.99M | — | — | — | — |
|
VYLR
Vylor Inc.
|
$45.73B | — | — | — | 2.2% |
|
CLUS
Cluster Group Holdings Ltd Co
|
$8.00B | — | — | — | — |
|
DMII
Drugs Made In America Acquisition II Corp.
|
$651.01M | +3.1% | — | — | 0.0% |
|
CCXI
Churchill Capital Corp XI
|
$627.18M | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| APMCR | -11.1% | -23.7% | — | -3.5% | — |
| SPY | -1.7% | -2.9% | +1.9% | -0.5% | +10.3% |
| vs SPY | -9.4% | -20.8% | — | -3.0% | — |
